BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,256,742 | -42.9% | 33,300 | -31.0% | 0.05% | -41.0% |
| Q2 2023 | $2,199,865 | +12.3% | 48,285 | 0.0% | 0.08% | +6.4% |
| Q1 2023 | $1,958,440 | -20.4% | 48,285 | 0.0% | 0.08% | -22.8% |
| Q4 2022 | $2,461,086 | -5.5% | 48,285 | -0.1% | 0.10% | -13.7% |
| Q3 2022 | $2,604,000 | -16.1% | 48,355 | +0.1% | 0.12% | -12.0% |
| Q2 2022 | $3,102,000 | -7.5% | 48,299 | +11.7% | 0.13% | +4.7% |
| Q1 2022 | $3,352,000 | -9.7% | 43,228 | 0.0% | 0.13% | -8.0% |
| Q4 2021 | $3,711,000 | +6.7% | 43,228 | -0.0% | 0.14% | -6.1% |
| Q3 2021 | $3,478,000 | -28.3% | 43,240 | -28.2% | 0.15% | -32.3% |
| Q2 2021 | $4,849,000 | -1.1% | 60,240 | +3.6% | 0.22% | -7.7% |
| Q1 2021 | $4,902,000 | +5.1% | 58,126 | 0.0% | 0.24% | -2.5% |
| Q4 2020 | $4,664,000 | +13.4% | 58,126 | +13.7% | 0.24% | -2.0% |
| Q3 2020 | $4,112,000 | -6.6% | 51,126 | +0.0% | 0.25% | -14.6% |
| Q2 2020 | $4,402,000 | +6.1% | 51,121 | +0.1% | 0.29% | -9.1% |
| Q1 2020 | $4,148,000 | +1.0% | 51,093 | +4.1% | 0.32% | +26.3% |
| Q4 2019 | $4,105,000 | -9.9% | 49,088 | -5.7% | 0.25% | -12.5% |
| Q3 2019 | $4,556,000 | +6.8% | 52,082 | +0.0% | 0.29% | +4.7% |
| Q2 2019 | $4,265,000 | +0.7% | 52,072 | +0.0% | 0.27% | -3.2% |
| Q1 2019 | $4,234,000 | +31.1% | 52,067 | +6.1% | 0.28% | +15.5% |
| Q4 2018 | $3,229,000 | -14.6% | 49,056 | 0.0% | 0.24% | -5.0% |
| Q3 2018 | $3,782,000 | +2.4% | 49,056 | -2.0% | 0.26% | -3.7% |
| Q2 2018 | $3,695,000 | +57.6% | 50,042 | +38.8% | 0.27% | +51.4% |
| Q1 2018 | $2,344,000 | +9.7% | 36,042 | +9.1% | 0.18% | +13.5% |
| Q4 2017 | $2,136,000 | +2.4% | 33,042 | -0.6% | 0.16% | -4.9% |
| Q3 2017 | $2,085,000 | +3.7% | 33,234 | +0.0% | 0.16% | -1.8% |
| Q2 2017 | $2,011,000 | +16.7% | 33,222 | 0.0% | 0.17% | +9.9% |
| Q1 2017 | $1,723,000 | +26.5% | 33,222 | +8.1% | 0.15% | +22.6% |
| Q4 2016 | $1,362,000 | -2.1% | 30,722 | +5.1% | 0.12% | -15.1% |
| Q3 2016 | $1,391,000 | -1.5% | 29,222 | -6.4% | 0.15% | -7.6% |
| Q2 2016 | $1,412,000 | +10.1% | 31,223 | -0.0% | 0.16% | +6.0% |
| Q1 2016 | $1,283,000 | +7.6% | 31,232 | 0.0% | 0.15% | 0.0% |
| Q4 2015 | $1,192,000 | +14.4% | 31,232 | -1.6% | 0.15% | +4.9% |
| Q3 2015 | $1,042,000 | -73.0% | 31,732 | -42.5% | 0.14% | -71.1% |
| Q2 2015 | $3,862,000 | +5.9% | 55,232 | +3.8% | 0.49% | +7.0% |
| Q1 2015 | $3,646,000 | -4.9% | 53,232 | +1.8% | 0.46% | -4.2% |
| Q4 2014 | $3,833,000 | +10.2% | 52,300 | +8.0% | 0.48% | +3.7% |
| Q3 2014 | $3,477,000 | +8.2% | 48,444 | +9.0% | 0.46% | +7.9% |
| Q2 2014 | $3,213,000 | -2.2% | 44,444 | -0.5% | 0.43% | -6.8% |
| Q1 2014 | $3,286,000 | +8.2% | 44,661 | +2.3% | 0.46% | +5.0% |
| Q4 2013 | $3,036,000 | +2.4% | 43,658 | -3.3% | 0.44% | -7.2% |
| Q3 2013 | $2,966,000 | -3.5% | 45,158 | +1.8% | 0.47% | -0.4% |
| Q2 2013 | $3,072,000 | – | 44,349 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |